List of works by Daniele Generali

A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial

scientific article published on 21 June 2016

A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers

scientific article

Advances in systemic therapy for malignant mesothelioma: future perspectives

scientific article published on 6 October 2017

Apatinib for the treatment of gastric cancer

scientific article published on 15 July 2016

Are EGFR tyrosine kinase inhibitors effective in elderly patients with EGFR-mutated non-small cell lung cancer?

scientific article published on 8 April 2017

Association between ramucirumab-related hypertension and response to treatment in patients with metastatic gastric cancer.

scientific article

Avelumab in gastric cancer

scientific article published on 06 May 2019

Bevacizumab in small cell lung cancer

scientific article published on September 2017

Breast tumour angiogenesis

scientific article published in January 2007

Characterization of MTAP Gene Expression in Breast Cancer Patients and Cell Lines

scientific article published on 11 January 2016

Circulating tumor cells correlate with patterns of recurrence in patients with hormone-sensitive prostate cancer.

scientific article

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data

scientific article

Corrigendum to “Gene expression profiling in breast cancer: A clinical perspective” [The Breast 22 (2013) 109–120]

article

Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?

scientific article

Current Status of Fibroblast Growth Factor Receptor-Targeted Therapies in Breast Cancer

scientific article published on 15 July 2018

Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer

scientific article published on 07 August 2018

Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

scientific article published on 10 November 2020

Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling

scientific article published on 21 August 2013

Enteric-coated and highly standardized cranberry extract reduces antibiotic and nonsteroidal anti-inflammatory drug use for urinary tract infections during radiotherapy for prostate carcinoma

scientific article

Epirubicin-based compared with docetaxel-based chemotherapy for advanced gastric carcinoma: A systematic review and meta-analysis

scientific article

Eribulin in heavily pretreated metastatic breast cancer patients and clinical/biological feature correlations: impact on the practice

scientific article published on January 2015

Everolimus-based therapy in patients with hormone receptor-positive, HER2(-) advanced breast cancer: management considerations

scientific article

Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study

scientific article published on 07 August 2020

Incidence and relative risk of adverse events of special interest in patients with castration resistant prostate cancer treated with CYP-17 inhibitors: A meta-analysis of published trials

scientific article published on 27 February 2016

Influence of Prior Tyrosine Kinase Inhibitor on Survival for Patients with Metastatic Renal Cell Carcinoma Treated with Nivolumab or Cabozantinib: Data from a Literature-based Meta-analysis

scientific article published on 28 July 2017

International expert consensus on primary systemic therapy in the management of early breast cancer: highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010).

scientific article published on January 2011

Is it time for everolimus-based combination in castration-resistant prostate cancer?

scientific article published on 2 June 2016

Is still there a place for orteronel in management of prostate cancer? Data from a literature based meta-analysis of randomized trials.

scientific article

Is still there a role for IL-2 for solid tumors other than melanoma or renal cancer?

scientific article published on January 2017

Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysis

scientific article published on 31 January 2018

Isolated Testicular Metastasis from Prostate Cancer.

scientific article published on 14 August 2017

Lenvatinib for the treatment of renal cell carcinoma.

scientific article published on 2 May 2018

Low dose versus standard dose of corticosteroids in the management of adverse events of special interest from abiraterone acetate: data from a literature-based meta-analysis.

scientific article published on 29 August 2017

Low-Dose Oral Ethinylestradiol With Concomitant Low-Dose Acetylsalicylic Acid for Advanced Castrate-Resistant Prostate Cancer.

scientific article

Lower urinary tract infections from external beam radiation therapy in prostate cancer: A single institution experience

scientific article published on 17 July 2018

Mutant p53 as an Antigen in Cancer Immunotherapy

scientific article published on 08 June 2020

Neoadjuvant chemotherapy and radical radiotherapy associated with cetuximab for laryngeal cancer in a pancreas and renal recipient

scientific article

New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials

scientific article published on 29 October 2016

New-Generation Hormone Therapies in Nonmetastatic Castration-Resistant Prostate Cancer: Why, Who, When

scientific article published on 06 February 2019

No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials.

scientific article

Optimal primary end point in Phase II trials of immune checkpoint inhibitors for advanced solid cancers: an evolving issue

scientific article published on 01 April 2019

PAK6-Associated Support Vector Machine Classifier: A New Way to Evaluate Response and Survival of Gastric Cancer Treated by 5-FU/Oxaliplatin Chemotherapy

scientific article published on 5 July 2017

Pertuzumab therapy for HER2-positive metastatic gastric or gastro-oesophageal junction cancer

scientific article published on 11 September 2018

Phase II study of weekly paclitaxel and sorafenib as second/third-line therapy in patients with adrenocortical carcinoma

scientific article

Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer

scientific article

Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press

scientific article published on 16 August 2016

Re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate C

scientific article

Response rate as a potential surrogate for survival and efficacy in patients treated with novel immune checkpoint inhibitors: A meta-regression of randomised prospective studies

scientific article

Risk of hypertension with ramucirumab-based therapy in solid tumors: data from a literature based meta-analysis.

scientific article

Role of targeted agents in neuroendocrine tumors: Results from a meta-analysis.

scientific article published on 14 July 2016

Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials

scientific article

Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737

scientific article published on 18 July 2011

Targeting bone metastatic cancer: Role of the mTOR pathway

scientific article published on 05 February 2014

Targeting the androgenic pathway in elderly patients with castration-resistant prostate cancer: A meta-analysis of randomized trials

scientific article

The Fibroblast Growth Factor Receptors in Breast Cancer: from Oncogenesis to Better Treatments ⬇️

scientific article published on 16 March 2020

The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis

scientific article published on 22 August 2013

The prognostic value of PI3K mutational status in breast cancer: a meta-analysis

scientific article published on 18 January 2018

The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen

scientific article

The role of bevacizumab in solid tumours: A literature based meta-analysis of randomised trials.

scientific article published on 24 February 2017

Tumor Infiltrating Lymphocytes in Multi-National Cohorts of Ductal Carcinoma In Situ (DCIS) of Breast

scientific article published in 2022

Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.

scientific article published on April 2017

Updates on the CDK4/6 Inhibitory Strategy and Combinations in Breast Cancer.

scientific article

Paulina is supported by:

About Paulina

Help